Milne Jill C. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Milne Jill C. has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Jill C. Milne serves as Chief Executive Officer and President of Astria Therapeutics, Inc., a biopharmaceutical company focused on therapies for rare allergic and immunological diseases. In the 2026-01-23 SEC filing (CIK 0001644246), Milne is listed as the CEO and President of Astria Therapeutics, overseeing the company's leadership, strategy, and ongoing preclinical programs such as STAR-0215 and STAR-0310.

Board memberships

• Astria Therapeutics, Inc.

Awards & honors

• Named CEO and President of Astria Therapeutics, Inc.
• Overseeing strategic direction and corporate governance for a biopharmaceutical company focused on rare diseases
• Guiding preclinical programs STAR-0215 and STAR-0310 through development and investor relations

Recent Transactions

Companies — Last 90 Days

• BIOCRYST PHARMACEUTICALS INC (BCRX) — 2 filings, last 2026-06-15

Frequently Asked Questions

Who is Milne Jill C.?

Jill C. Milne serves as Chief Executive Officer and President of Astria Therapeutics, Inc., a biopharmaceutical company focused on therapies for rare allergic and immunological diseases. In the 2026-01-23 SEC filing (CIK 0001644246), Milne is listed as the CEO and President of Astria Therapeutics, overseeing the company's leadership, strategy, and ongoing preclinical programs s…

How many SEC Form 4 filings has Milne Jill C. submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Milne Jill C.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week